AYURVEDIC MANAGEMENT OF STATIN-REFRACTORY DYSLIPIDEMIA THROUGH VIRECHANA KARMA: A DETAILED CASE REPORT
International Ayurvedic Medical Journal · 18.02.2026 · 688
DOI: 10.46607/iamj5114022026 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Ayurvedic Medical Journal, online erschienen am 18.02.2026. Verfasst von Minal Hariom Gupta und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Dyslipidemia is a major cardiovascular risk factor, and long-term statin therapy may be associated with inadequate response or tolerability issues in some patients. In Ayurveda, the concept of dyslipidemia can be understood under the following contexts: Santarpanotta Vikara(diseases caused by over nutrition) - Prameha and Sthoulya Purvaroopa; Snehamsha Vruddi - Rasa Dhatu; Ama (toxic, undigested metabolic waste) Medo Dhatu(adipose or fat tissue); and Medo Roga(disorder of lipid and fat metabolism)/ Medo Dushti. Ayurveda of-fers biopurification therapies that address underlying metabolic dysfunction rather than simply providing symp-tomatic relief. Case presentation: A 50-year-old male with persistent dyslipidemia despite four years of atorvastatin therapy presented with fatigue, lethargy, body heaviness (Gaurava), excessive sweating (Atiswedana), and breathless-ness on exertion (Ayase Shwasa). Based on Ayurvedic assessment suggestive of Medoroga (disorder of fat me-tabolism) and Agnimandya (diminished digestive and metabolic capacity), the patient underwent Virechana Karma (therapeutic purgation therapy) following appropriate Deepana-Pachana(appetite stimulating and diges-tion enhancing therapy) and Snehapana(internal oleation therapy), followed by Shamana Aushadhi(Palliative therapy) including Rasonadi Kashayam and Arogyavardhini Vati. Post-treatment evaluation showed a 32.3% reduction in total cholesterol and a 71.9% reduction in triglycerides, along with improvement in LDL levels, body weight, and clinical symptoms. No adverse effects were observed, and results were sustained during fol-low-up.
Conclusion
This case highlights that Virechana Karma, when appropriately planned and executed, can offer a safe and effective therapeutic option for statin-refractory dyslipidemia by correcting underlying metabolic imbal-ance. The findings suggest a potential role for Ayurvedic bio-purification therapies as a sustainable alternative or adjunct in the management of dyslipidemia.
Zitieren
APA
Gupta, M. H., & Neralkar, U. K. (2026). AYURVEDIC MANAGEMENT OF STATIN-REFRACTORY DYSLIPIDEMIA THROUGH VIRECHANA KARMA: A DETAILED CASE REPORT. International Ayurvedic Medical Journal, 688. https://doi.org/10.46607/iamj5114022026
Vancouver
Gupta MH, Neralkar UK. AYURVEDIC MANAGEMENT OF STATIN-REFRACTORY DYSLIPIDEMIA THROUGH VIRECHANA KARMA: A DETAILED CASE REPORT. International Ayurvedic Medical Journal. 2026:688. doi:10.46607/iamj5114022026
BibTeX
@article{Gupta2026,
author = {Gupta, Minal Hariom and Neralkar, Uday Keshavrao},
title = {AYURVEDIC MANAGEMENT OF STATIN-REFRACTORY DYSLIPIDEMIA THROUGH VIRECHANA KARMA: A DETAILED CASE REPORT},
journal = {International Ayurvedic Medical Journal},
year = {2026},
pages = {688},
doi = {10.46607/iamj5114022026}
}
EUVIMED